Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma
Clinical trial NCT02215967 · COMPLETED
Trial details
- NCT number
- NCT02215967
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-12
- Primary completion
- 2019-04-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.